Cargando…
A natural PKM2 targeting agent as a potential drug for breast cancer treatment
Autores principales: | Shang, Xin‐Yue, Wang, Yu‐Jue, Hou, Zi‐Lin, Wang, Xin‐Ye, Zhang, Hao, Yang, Chen‐Yu, Li, Ji‐Chong, Huang, Xiao‐Xiao, Song, Shao‐Jiang, Yao, Guo‐Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798039/ https://www.ncbi.nlm.nih.gov/pubmed/36579385 http://dx.doi.org/10.1002/ctm2.1157 |
Ejemplares similares
-
Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells
por: Wang, Zhimin, et al.
Publicado: (2022) -
PKM2 regulates Gli1 expression in hepatocellular carcinoma
por: XU, QIURAN, et al.
Publicado: (2014) -
PKM2 and cancer: The function of PKM2 beyond glycolysis
por: DONG, GAOCHAO, et al.
Publicado: (2016) -
The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer
por: Wang, Jing‐Zi, et al.
Publicado: (2021) -
PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
por: Xiao, Hui, et al.
Publicado: (2020)